CoChat

Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases

Open access
Zhang, Siyuan, Huang, Wen-Chien, Zhang, Lin, Zhang, Chenyu, Lowery, Frank J., Ding, Zhaoxi, Guo, Hua, Wang, Hai, Huang, Suyun, Sahin, Aysegul A., Aldape, Kenneth D., Steeg, Patricia S., Yu, Dihua · 2013 · Cancer Research
Cited by 125

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Despite better control of early-stage disease and improved overall survival of patients with breast cancer, the incidence of life-threatening brain metastases continues to increase in some of these patients. Unfortunately, other than palliative treatments there is no effective therapy for this condition. In this study, we reveal a critical role for Src activation in promoting brain metastasis in a preclinical model of breast cancer and we show how Src-targeting combinatorial regimens can treat HER2+ brain metastases in this model. We found that Src was hyperactivated in brain-seeking breast cancer cells derived from human cell lines or from patients' brain metastases. Mechanistically, Src activation promoted tumor cell extravasation into the brain parenchyma via permeabilization of the blood–brain barrier. When combined with the EGFR/HER2 dual-targeting drug lapatinib, an Src-targeting combinatorial regimen prevented outgrowth of disseminated breast cancer cells through the induction of cell-cycle arrest. More importantly, this combinatorial regimen inhibited the outgrowth of established experimental brain metastases, prolonging the survival of metastases-bearing mice. Our results provide a rationale for clinical evaluation of Src-targeting regimens to treat patients with breast cancer suffering from brain metastasis. Cancer Res; 73(18); 5764–74. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-1803

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 125

Metadata

Authors
Zhang, S., Huang, W.-C., Zhang, L., Zhang, C., Lowery, F. J., Ding, Z., Guo, H., Wang, H., Huang, S., Sahin, A. A., Aldape, K. D., Steeg, P. S., & Yu, D.
Venue
Cancer Research
Published
2013-09-15
Volume
73
Issue
18
Pages
5764-5774
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2120689337
Cited by
125
References
8
FWCI
9.26
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-1803
The paper
Zhang, S., Huang, W.-C., Zhang, L., Zhang, C., Lowery, F. J., Ding, Z., Guo, H., Wang, H., Huang, S., Sahin, A. A., Aldape, K. D., Steeg, P. S., & Yu, D. (2013). Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-1803

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.